2024
Nuclear Cardiology
Zaret B, Wackers F. Nuclear Cardiology. 2024, 3-12. DOI: 10.1093/med/9780190095659.003.0001.Peer-Reviewed Original ResearchEvaluate left ventricular (LV) functionQuantification of coronary blood flowPerfusion imagingRadiation dose reductionPET-FDG studiesStress perfusion imagingEvaluate myocardial perfusionCoronary flow reserveMyocardial perfusion studiesComputed tomography CTCardiac sarcoidosisCoronary blood flowDose reductionMyocardial inflammationSPECT approachAssess prognosisMyocardial stress perfusion imagingStress imagingMyocardial perfusionFlow reservePerfusion studiesCardiac studiesRadionuclide imagingBlood flowAttenuation correctionNuclear Cardiology
Zaret B, Wackers F. Nuclear Cardiology. 2024, 1-1. DOI: 10.1093/med/9780197521434.003.0001.Peer-Reviewed Original ResearchEvaluate left ventricular (LV) functionQuantification of coronary blood flowPerfusion imagingRadiation dose reductionPET-FDG studiesStress perfusion imagingEvaluate myocardial perfusionCoronary flow reserveMyocardial perfusion studiesComputed tomography CTCardiac sarcoidosisCoronary blood flowDose reductionMyocardial inflammationSPECT approachAssess prognosisMyocardial stress perfusion imagingStress imagingMyocardial perfusionFlow reservePerfusion studiesCardiac studiesRadionuclide imagingBlood flowAttenuation correction
1991
Thallium-201 for assessment of myocardial viability: Quantitative comparison of 24-hour redistribution imaging with imaging after reinjection at rest
Kayden D, Sigal S, Soufer R, Mattera J, Zaret B, Wackers F. Thallium-201 for assessment of myocardial viability: Quantitative comparison of 24-hour redistribution imaging with imaging after reinjection at rest. Journal Of The American College Of Cardiology 1991, 18: 1480-1486. PMID: 1939949, DOI: 10.1016/0735-1097(91)90678-3.Peer-Reviewed Original ResearchConceptsInjection of thalliumRedistribution imagesDefect reversibilityThallium-201 reinjectionThallium-201 defectsLate redistribution imagingPoor quality studiesDiagnostic informationClinical variablesRedistribution imagingThallium defectsThallium imagesMyocardial viabilityReversible defectsStress imagingThallium-201PatientsBetter diagnostic informationStress testingExercisePresent studyQuality studiesInjectionLate redistributionReinjection
1989
Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.
Wackers F, Berman D, Maddahi J, Watson D, Beller G, Strauss H, Boucher C, Picard M, Holman B, Fridrich R. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. Journal Of Nuclear Medicine 1989, 30: 301-11. PMID: 2525610.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseArtery diseaseMulticenter phase II clinical trialSignificant coronary artery diseasePhase II clinical trialMulticenter phase IStress imagesMyocardial perfusion imagingNew myocardial imaging agentHuman biodistributionClinical efficacyClinical trialsMyocardial analysisStress imagingMyocardial imaging agentMyocardial uptakeMyocardial segmentsNormal volunteersThallium-201Myocardial imagingPerfusion imagingPatientsPhase IExact concordanceMyocardial images